Zelira Therapeutics (AU:ZLD) has released an update.
Zelira Therapeutics is preparing for its 2024 Annual Shareholders General Meeting, offering investors insights into its future plans and strategies. While the company outlines its expectations and strategic directions, it emphasizes that many external factors may influence its performance. Potential investors are encouraged to conduct their own research before making any investment decisions.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.